LRMR
Price
$2.33
Change
-$0.04 (-1.69%)
Updated
Apr 25 closing price
Capitalization
149.18M
10 days until earnings call
XFOR
Price
$0.19
Change
-$0.00 (-0.00%)
Updated
Apr 25 closing price
Capitalization
989.88M
3 days until earnings call
Ad is loading...

LRMR vs XFOR

Header iconLRMR vs XFOR Comparison
Open Charts LRMR vs XFORBanner chart's image
Larimar Therapeutics
Price$2.33
Change-$0.04 (-1.69%)
Volume$628.66K
Capitalization149.18M
X4 Pharmaceuticals
Price$0.19
Change-$0.00 (-0.00%)
Volume$1.83M
Capitalization989.88M
LRMR vs XFOR Comparison Chart
Loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LRMR vs. XFOR commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a Buy and XFOR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (LRMR: $2.33 vs. XFOR: $0.19)
Brand notoriety: LRMR and XFOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 72% vs. XFOR: 109%
Market capitalization -- LRMR: $149.18M vs. XFOR: $989.88M
LRMR [@Biotechnology] is valued at $149.18M. XFOR’s [@Biotechnology] market capitalization is $989.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 0 FA rating(s) are green whileXFOR’s FA Score has 0 green FA rating(s).

  • LRMR’s FA Score: 0 green, 5 red.
  • XFOR’s FA Score: 0 green, 5 red.
According to our system of comparison, LRMR is a better buy in the long-term than XFOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 4 TA indicator(s) are bullish while XFOR’s TA Score has 5 bullish TA indicator(s).

  • LRMR’s TA Score: 4 bullish, 4 bearish.
  • XFOR’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, XFOR is a better buy in the short-term than LRMR.

Price Growth

LRMR (@Biotechnology) experienced а +21.99% price change this week, while XFOR (@Biotechnology) price change was -0.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

Reported Earning Dates

LRMR is expected to report earnings on Aug 07, 2025.

XFOR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XFOR($990M) has a higher market cap than LRMR($149M). LRMR YTD gains are higher at: -39.793 vs. XFOR (-74.100). XFOR has higher annual earnings (EBITDA): -7.74M vs. LRMR (-73.44M). LRMR has more cash in the bank: 204M vs. XFOR (135M). LRMR has less debt than XFOR: LRMR (5.36M) vs XFOR (78.2M). XFOR has higher revenues than LRMR: XFOR (1.12M) vs LRMR (0).
LRMRXFORLRMR / XFOR
Capitalization149M990M15%
EBITDA-73.44M-7.74M949%
Gain YTD-39.793-74.10054%
P/E RatioN/A3.10-
Revenue01.12M-
Total Cash204M135M151%
Total Debt5.36M78.2M7%
FUNDAMENTALS RATINGS
LRMR vs XFOR: Fundamental Ratings
LRMR
XFOR
OUTLOOK RATING
1..100
3971
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
6596
P/E GROWTH RATING
1..100
10086
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (50) in the null industry is in the same range as XFOR (50) in the Biotechnology industry. This means that LRMR’s stock grew similarly to XFOR’s over the last 12 months.

LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as XFOR (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to XFOR’s over the last 12 months.

XFOR's SMR Rating (93) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that XFOR’s stock grew similarly to LRMR’s over the last 12 months.

LRMR's Price Growth Rating (65) in the null industry is in the same range as XFOR (96) in the Biotechnology industry. This means that LRMR’s stock grew similarly to XFOR’s over the last 12 months.

XFOR's P/E Growth Rating (86) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that XFOR’s stock grew similarly to LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LRMRXFOR
RSI
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 20 days ago
80%
Declines
ODDS (%)
Bearish Trend 21 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
87%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAKEX19.940.17
+0.86%
Oakmark International Small Cap Investor
KAUAX5.220.04
+0.77%
Federated Hermes Kaufmann A
SMYIX23.860.15
+0.63%
Franklin Global Equity I
GPROX14.73-0.03
-0.20%
Grandeur Peak Global Reach Inv
PVCCX10.92-0.03
-0.27%
Victory Pioneer Intrinsic Value C

XFOR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XFOR has been loosely correlated with IMMP. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if XFOR jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XFOR
1D Price
Change %
XFOR100%
+1.50%
IMMP - XFOR
37%
Loosely correlated
-2.98%
XCUR - XFOR
34%
Loosely correlated
-3.01%
SPHDF - XFOR
34%
Loosely correlated
N/A
LRMR - XFOR
31%
Poorly correlated
-1.69%
CRDF - XFOR
30%
Poorly correlated
-0.69%
More